Abbott Laboratories
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
67/100
High Influence
$26.6M
Total Lobby Spend
6
Policy Issues
10
Lobbyists
4
Revolving Door
Abbott Laboratories reported $26.6 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Medical/Disease Research, Pharmacy. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Office of Management & Budget
Securities & Exchange Commission
Dept of State
Dept of Commerce
Dept of Health & Human Services
Dept of Treasury
Centers for Medicare & Medicaid Services
US House of Representatives
Federal Energy Regulatory Commission
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Covington & Burling LLP | MEDTRDPHA | 4 | $1.1M |
| 2020 Apr-Jun | BGR Group LLP | TRDPHATAX | 2 | $1.7M |
| 2020 Jul-Sep | K&L Gates LLP | HCRTAXMED | 1 | $1.1M |
| 2020 Oct-Dec | BGR Group LLP | MEDTRDHCR | 1 | $1.9M |
| 2021 Jan-Mar | BGR Group LLP | TRDHCRGOV+2 | 4 | $1.1M |
| 2021 Apr-Jun | Cassidy & Associates LLP | MEDTRDTAX | 1 | $1.1M |
| 2021 Jul-Sep | Cassidy & Associates LLP | HCRTRDTAX+2 | 2 | $1.1M |
| 2021 Oct-Dec | Covington & Burling LLP | MED | 4 | $1.4M |